Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-10 Tax Withholding | 2025-12-12 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,013 | $4.1 | 3,622 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-08 5:30 pm | N/A 2035-08-07 | Cullinan Therapeutics Inc. | CGEM | Doyle Mittie Director | 79,456 | $0 | 79,456 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-30 5:20 pm | N/A 2035-01-28 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2024-07-15 Option Award | 2024-07-16 4:23 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 234,000 | $0 | 234,000 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-01 6:27 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 42,500 | $0 | 42,500 (Direct) | View |
Ownership | 2022-04-01 6:12 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 0 | $0 | 0 (Direct) | View |